| 1 |
35059243 | The forgotten type 2 diabetes mellitus medicine: rosiglitazone. | 2022 Jan |
1 |
| 2 |
23024191 | Glitazones exert multiple effects on β-cell stimulus-secretion coupling. | 2013 Jan |
1 |
| 3 |
21081660 | A gene expression signature for insulin resistance. | 2011 Feb 11 |
1 |
| 4 |
21779873 | Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program. | 2011 Oct |
2 |
| 5 |
20805226 | Palmitate-induced down-regulation of sortilin and impaired GLUT4 trafficking in C2C12 myotubes. | 2010 Nov 5 |
1 |
| 6 |
21105563 | Metformin and troglitazone in the treatment of female infertility associated with polycystic ovarian syndrome. | 2009 Oct-Dec |
1 |
| 7 |
18284435 | Adiponectin and its response to thiazolidinediones are associated with insulin-mediated glucose metabolism in type 2 diabetic patients and their first-degree relatives. | 2008 Nov |
2 |
| 8 |
17716671 | Conditioned medium obtained from in vitro differentiated adipocytes and resistin induce insulin resistance in human hepatocytes. | 2007 Sep 4 |
1 |
| 9 |
16246375 | Effect of ecdysterone on glucose metabolism in vitro. | 2006 Feb 2 |
2 |
| 10 |
16483873 | Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture. | 2006 Mar |
3 |
| 11 |
16677059 | Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities. | 2006 |
3 |
| 12 |
16801577 | Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes. | 2006 Jul |
3 |
| 13 |
15793255 | Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. | 2005 Apr |
2 |
| 14 |
15798962 | Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones. | 2005 Apr |
1 |
| 15 |
15834551 | Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells. | 2005 May |
1 |
| 16 |
16020878 | Insulin resistance contributes to obesity-related proteinuria. | 2005 Jun |
2 |
| 17 |
16039647 | Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. | 2005 Aug 22 |
1 |
| 18 |
16093575 | Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity. | 2005 Jul-Aug |
1 |
| 19 |
16115720 | Detection of autoantibody to aldolase B in sera from patients with troglitazone-induced liver dysfunction. | 2005 Dec |
1 |
| 20 |
16179348 | Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors. | 2005 Nov 18 |
3 |
| 21 |
16232315 | Prevalence, predisposition and prevention of type II diabetes. | 2005 Oct 18 |
1 |
| 22 |
16388091 | The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease. | 2005 Nov |
1 |
| 23 |
14693409 | Decrease in serum C-reactive protein levels by troglitazone is associated with pretreatment insulin resistance, but independent of its effect on glycemia, in type 2 diabetic subjects. | 2004 Jan |
3 |
| 24 |
14693981 | Effects of troglitazone in young first-degree relatives of patients with type 2 diabetes. | 2004 Jan |
4 |
| 25 |
15117549 | Ethanol impairs insulin's actions through phosphatidylinositol 3-kinase. | 2004 Spring |
1 |
| 26 |
15161789 | Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study. | 2004 Jun |
1 |
| 27 |
15311105 | Improvement of insulin resistance by troglitazone ameliorates cardiac sympathetic nervous dysfunction in patients with essential hypertension. | 2004 Sep |
4 |
| 28 |
15316457 | Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes. | 2004 Sep |
1 |
| 29 |
15733404 | [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome]. | 2004 Dec |
3 |
| 30 |
12574183 | Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome. | 2003 Feb |
2 |
| 31 |
12601628 | The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. | 2003 Feb |
1 |
| 32 |
12639698 | Acute effects of troglitazone and nitric oxide on glucose uptake in L929 fibroblast cells. | 2003 Apr 11 |
2 |
| 33 |
12728539 | Long-term cardiovascular effects of insulin sensitizer troglitazone on non-diabetic individuals with insulin resistance: double blind, prospective randomized study. | 2003 Apr |
6 |
| 34 |
12732844 | A study to survey susceptible genetic factors responsible for troglitazone-associated hepatotoxicity in Japanese patients with type 2 diabetes mellitus. | 2003 May |
1 |
| 35 |
12749433 | Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. | 2003 Apr |
4 |
| 36 |
12914525 | Insulin-sparing effects of troglitazone in rat pancreatic islets. | 2003 Aug |
3 |
| 37 |
12917943 | Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. | 2003 |
1 |
| 38 |
14506629 | The impact of an insulin sensitizer, troglitazone, on glucose metabolism in African Americans at risk for type 2 diabetes mellitus: a placebo-controlled, 24-month randomized study. | 2003 Sep |
1 |
| 39 |
14556818 | Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. | 2003 Oct |
2 |
| 40 |
14570054 | [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus]. | 2003 |
1 |
| 41 |
14602740 | Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. | 2003 Nov |
5 |
| 42 |
11751282 | Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. | 2002 Jan |
3 |
| 43 |
11756319 | Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. | 2002 Jan |
4 |
| 44 |
11812753 | Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. | 2002 Feb |
4 |
| 45 |
11833043 | Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus. | 2002 Feb |
2 |
| 46 |
11874944 | Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. | 2002 Mar |
3 |
| 47 |
11889176 | Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro. | 2002 Mar |
8 |
| 48 |
11947963 | Troglitazone improves GLUT4 expression in adipose tissue in an animal model of obese type 2 diabetes mellitus. | 2002 Jun |
4 |
| 49 |
12009391 | Troglitazone: a possible modulator of ovarian steroidogenesis. | 2002 May-Jun |
3 |
| 50 |
12145147 | Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. | 2002 Aug |
3 |